Please login to the form below

Not currently logged in
Email:
Password:

linaclotide

This page shows the latest linaclotide news and features for those working in and with pharma, biotech and healthcare.

China approves Ironwood Pharma’s IBS treatment

China approves Ironwood Pharma’s IBS treatment

AstraZeneca '. primarily responsible' on commercialisation across the vast country. Tom McCourt, Ironwood's new president said: “Regulatory approval in China represents another important step in bringing linaclotide to millions of adult

Latest news

More from news
Approximately 2 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    years. Among a newer generation of orally-delivered peptides is Ironwood Pharma's peptide drug Linzess/Constella (linaclotide) - which debuted in 2012 for constipation associated with irritable bowel syndrome.

  • Pharma deals during October 2012 Pharma deals during October 2012

    In addition, Ironwood could receive a further $125m in milestones if certain sales targets for linaclotide are met. . ... 153. Ironwood / AstraZeneca. Co-develop &co-commercialise (profit/ loss share). Linaclotide, IBS with constipation (FDA approved).

  • Interview: Jorge Gallardo, Almirall Interview: Jorge Gallardo, Almirall

    pulmonary disease (COPD) and linaclotide indicated for irritable bowel syndrome with constipation, for which there is no specific treatment approved by the European Medicines Agency (EMA).

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Ironwood appoints Edward Owens to board Ironwood appoints Edward Owens to board

    Owens is a former partner at investments advisor Wellington Management, and joins the US-based biopharma at a time of growth following the approval of Linzess (linaclotide) in the US for

  • Ironwood promotes Dr Mark Currie Ironwood promotes Dr Mark Currie

    Currie's academic research on the guanylate cyclase-C (GC-C) pathway laid the foundation for the discovery by Ironwood scientists of linaclotide. ... Linaclotide was approved as a treatment for irritable bowel syndrome last year by regulators in Europe,

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics